Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Active Disease
16%
Central Nervous System Tuberculosis
16%
Corticosteroid Therapy
16%
Enhancing Lesions
16%
Evidence-based Guidelines
16%
First-line Drugs
33%
HIV Prevalence
16%
Incidence/prevalence
16%
Inflammatory Response
16%
International Guidelines
16%
Intracranial Mass Lesions
16%
Intracranial Tuberculoma
16%
Lesional
16%
Mass Lesion
100%
Medical Treatment
16%
Mycobacterium Tuberculosis (M. tb)
16%
Mycobacterium Tuberculosis Strains
33%
Peer Review
100%
Potentially Toxic
16%
Prospective Clinical Trial
16%
Radiological Features
16%
Revascularization
16%
TB Incidence
16%
Toxic Drugs
16%
Treatment Duration
33%
Treatment Failure
16%
Treatment Practices
16%
Treatment Response
16%
Treatment Therapies
16%
Tuberculoma
33%
Tuberculosis Therapy
16%
Tuberculosis Treatment
100%
Tuberculous Abscess
33%
Tuberculous Meningitis
16%
Medicine and Dentistry
Abscess
33%
Central Nervous System Tuberculosis
16%
Clinical Trial
16%
Clinician
16%
Corticosteroid Therapy
16%
Diseases
16%
Enhancing Lesion
16%
Human Immunodeficiency Virus
16%
Intracranial Tuberculoma
16%
Mycobacterium Tuberculosis
33%
Prevalence
16%
Revascularization
16%
Serositis
16%
Treatment Duration
33%
Treatment Response
16%
Tuberculoma
33%
Tuberculosis
50%
Tuberculosis Treatment
100%
Tuberculous Meningitis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Abscess
22%
Central Nervous System Tuberculosis
11%
Clinical Trial
11%
Corticosteroid
11%
Diseases
11%
HIV
11%
Inflammation
11%
Intracranial Tuberculoma
11%
Mycobacterium Tuberculosis
22%
Prevalence
11%
Tuberculoma
22%
Tuberculosis
100%
Tuberculous Meningitis
11%